Picture of China Resources Pharmaceutical logo

3320 — China Resources Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Brief: China Resources Pharmaceutical Says HY Revenue For KPC Pharmaceuticals RMB3.77 Bln

Aug 30 (Reuters) - China Resources Pharmaceutical Group
Ltd  3320.HK :
    * HY REVENUE FOR KPC PHARMACEUTICALS RMB3.77 BILLION VERSUS
RMB4.23 BILLION
    * HY NET PROFIT ATTRIBUTABLE FOR KPC PHARMACEUTICALS
RMB223.4
MILLION VERSUS RMB216.6 MILLION

Source text for Eikon:  ID:nHKS2k473X 
Further company coverage:  3320.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on China Resources Pharmaceutical

See all news